119 related articles for article (PubMed ID: 27125872)
1. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma.
Xia WK; Liu ZL; Shen D; Lin QF; Su J; Mao WD
World J Surg Oncol; 2016 Apr; 14():127. PubMed ID: 27125872
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.
Kusama H; Kittaka N; Soma A; Taniguchi A; Kanaoka H; Nakajima S; Oyama Y; Seto Y; Okuno J; Watanabe N; Matsui S; Nishio M; Fujisawa F; Honma K; Tamaki Y; Nakayama T
Breast Cancer; 2023 Nov; 30(6):1085-1093. PubMed ID: 37782377
[TBL] [Abstract][Full Text] [Related]
3. D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC.
Hu H; Chen WJ; Sun C; Xie JP
Medicine (Baltimore); 2023 Nov; 102(45):e34877. PubMed ID: 37960828
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Liu M; Feng Y; Zhang Y; Liu H
Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to predict Surgical Site Infection?
Erciyestepe SG; Boran AB; Yildirim MS; Erciyestepe M
Malawi Med J; 2023 Sep; 35(3):190-195. PubMed ID: 38362285
[TBL] [Abstract][Full Text] [Related]
6. The ratio of lymphocyte/red blood cells and platelets/lymphocytes are predictive biomarkers for lymph node metastasis in patients with breast cancer.
Wang H; Yu J; Shen W; Zhao H; Cui J; Gao B
Cancer Biomark; 2023; 38(4):595-602. PubMed ID: 38143337
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of platelet-to-lymphocyte ratio combined with CA199 levels in postoperative survival of patients with gastric cancer: A retrospective study.
Shi X; Li S; Wang Y; Liu C; Liu P; Qin D
Int Immunopharmacol; 2023 Nov; 124(Pt B):110987. PubMed ID: 37806105
[TBL] [Abstract][Full Text] [Related]
8. The combination of baseline neutrophil to lymphocyte ratio and dynamic changes during treatment can better predict the survival of osteosarcoma patients.
Li L; Li Y; Lu M; Wang Y; Li Z; Hu X; He X; Gong T; Luo Y; Zhou Y; Min L; Tu C
Front Oncol; 2023; 13():1235158. PubMed ID: 38033504
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.
Kachuri L; Jeon S; DeWan AT; Metayer C; Ma X; Witte JS; Chiang CWK; Wiemels JL; de Smith AJ
Am J Hum Genet; 2021 Oct; 108(10):1823-1835. PubMed ID: 34469753
[TBL] [Abstract][Full Text] [Related]
10. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.
Li X; Zhang Y; Zhu C; Xu W; Hu X; Martínez DAS; Romero JLA; Yan M; Dai Y; Wang H
BMC Womens Health; 2024 Jan; 24(1):38. PubMed ID: 38218823
[TBL] [Abstract][Full Text] [Related]
11. Significance of the Pretreatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting the Response to Neoadjuvant Chemotherapy and Survival Rates in Extremity Osteosarcoma: A Multicentre Prospective Study.
Arefpour AM; Garousi M; Foroughi A; Hosseini S; Shahin M; Javadinia SA
Cancer Invest; 2023 Dec; 41(10):816-820. PubMed ID: 37963292
[TBL] [Abstract][Full Text] [Related]
12. SYSTEMIC INFLAMMATORY INDICES IN PATIENTS WITH MALIGNANT GLIOMAS AND EFFECTS OF PLATELET SECRETOME IN VITRO.
Rozumenko V; Liubich L; Pedachenko E; Staino L; Egorova D; Kot L; Malysheva T
Exp Oncol; 2024 Feb; 45(4):409-420. PubMed ID: 38328849
[TBL] [Abstract][Full Text] [Related]
13. Serum pro-surfactant protein B is correlated with clinical properties in osteosarcoma patients.
Feng S; Fu D; Zhang Y; Zhang L; Ji Y; Li H; A L
Biochem Cell Biol; 2023 Oct; 101(5):456-463. PubMed ID: 37192548
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.
Yang S; Wu C; Wang L; Shan D; Chen B
Int J Clin Exp Pathol; 2020; 13(3):515-524. PubMed ID: 32269690
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of inflammation-based scores in patients with osteosarcoma.
Liu B; Huang Y; Sun Y; Zhang J; Yao Y; Shen Z; Xiang D; He A
Sci Rep; 2016 Dec; 6():39862. PubMed ID: 28008988
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma.
Huang X; Hu H; Zhang W; Shao Z
J Cell Physiol; 2019 Aug; 234(10):18408-18414. PubMed ID: 30891768
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma.
Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ
Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas.
Vasquez L; León E; Beltran B; Maza I; Oscanoa M; Geronimo J
J Pediatr Hematol Oncol; 2017 Oct; 39(7):538-546. PubMed ID: 28697168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
